Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Recruiting
200 enrolled
ReAL
Recruiting
5,000 enrolled
EUREKA
Recruiting
400 enrolled
ProDigALIty
Recruiting
760 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
REMAKE
Not yet recruiting
300 enrolled
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Recruiting
400 enrolled
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Recruiting
1,000 enrolled
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Collection of Tissue Samples for Cancer Research
Recruiting
5,000 enrolled
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Completed
1,892 enrolled
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Recruiting
500 enrolled
Connect® MM- The Multiple Myeloma Disease Registry
Terminated
3,011 enrolled
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
2,000 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Suspended
2,400 enrolled
MoMMent
Recruiting
300 enrolled
RHUMM
Active not recruiting
180 enrolled
TEC-CARE
Active not recruiting
200 enrolled
REALiTEC/TAL
Recruiting
900 enrolled
A Real-world Study in Participants With Smoldering Multiple Myeloma
Completed
431 enrolled
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
Recruiting
70 enrolled
TRANSFORMM
Recruiting
1,000 enrolled
Tissue Collection for Studies of Lymph Cancer
Recruiting
1,295 enrolled
Study of CAR-T Therapy in Older Patients
Recruiting
154 enrolled
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Recruiting
127 enrolled
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Recruiting
50 enrolled
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Active not recruiting
656 enrolled
ITA-WebNet
Recruiting
1,000 enrolled
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Recruiting
48 enrolled
B-SCR-MM
Recruiting
5,000 enrolled
MUST
Active not recruiting
250 enrolled
MMExFFPE
Not yet recruiting
15 enrolled
MM-t4-14-FFPE
Not yet recruiting
20 enrolled
MED-hATTR
Completed
37 enrolled
LTFS
Enrolling by invitation
150 enrolled
Rapid dFLC Response Predict CHR in AL Amyloidosis
Recruiting
50 enrolled
Agriculture Health Study
Active not recruiting
89,655 enrolled
A Study of Ninlaro in Real World Clinical Practice in China
Completed
482 enrolled
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Terminated
50 enrolled
GlycAL
Recruiting
100 enrolled
ALPS
Recruiting
100 enrolled
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Active not recruiting
69 enrolled
Biomarkers of AKI in Patients Receiving Daratumumab
Completed
20 enrolled
BE.Amycon Biobank & Data Registry UZ Leuven
Recruiting
505 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Recruiting
700 enrolled
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Active not recruiting
49 enrolled
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Recruiting
75 enrolled
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Not yet recruiting
30 enrolled